|Bid||0.00 x 0|
|Ask||671.25 x 0|
|Day's range||663.50 - 674.75|
|52-week range||315.20 - 674.75|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||223.08|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
New Delhi, Jun 13 (PTI) Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up, as per a top company official.
New Delhi, Jun 2 (PTI) Drug major Sun Pharmaceutical Industries on Wednesday said it has entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India.
New Delhi, May 28 (PTI) Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca Pharma India's parent company.